Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -191.67M | $ -0.72 | 0.17 | 1.58B |
3/31/2025 | $ -109.83M | $ -0.43 | 0.17 | 1.54B |
12/31/2024 | $ -74.09M | $ -0.29 | 0.17 | 1.51B |
9/30/2024 | $ -55.17M | $ -0.22 | 0.17 | 1.53B |
6/30/2024 | $ -46.03M | $ -0.18 | 0.17 | 1.53B |
3/31/2024 | $ -137.98M | $ -0.57 | 0.17 | 1.45B |
12/31/2023 | $ -145.56M | $ -0.72 | 0.17 | 1.21B |
9/30/2023 | $ -131.43M | $ -0.58 | 0.17 | 1.36B |
6/30/2023 | $ -144.15M | $ -0.78 | 0.17 | 1.11B |
3/31/2023 | $ -149.38M | $ -0.9 | 0.17 | 991.33M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: FCF [ $ -38.24M ] / (Shares WA [ 928.02M ] * Share Factor [ 0.17 ])
(=) FCFPS [ $ -0.25 ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |